Shah Gaurav sold 3,020 shares of ROCKET PHARMACEUTICALS, INC. at $2.25 for −$6.80k on Nov 13, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
CEO
CEO
Filed Nov 17, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$6,795Shares × reported price
Shares traded
3,020Common Stock
Price per share
$2.25Reported price. Read footnotes for ranges.
% of reported position traded
0.29%This security and ownership context
Holdings after
1,053,574Direct
Trade date
Nov 13, 2026Sell
Filed
Nov 17, 2026, 5:17 PM ET4-day reporting delay
Accession
0001140361-26-044546Code S · Transaction 404177
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 1,056,594 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

RCKT price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
RCKT · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 24, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago +4.7%1w ago +22%1d ago +13%
Returns since7d30d90d180d1y

Footnotes in full

F1: Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis. F2: The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.